CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS CALT 深 沪
等待开盘 08-02 09:30:00 美东时间
40.0001
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 40.0001
- 总市值 10.81亿
- 52周最高 3.4777
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 -24.2723
- 委 比 0.00%
- 总股本 2701.67万
- 历史最高 3.4777
- 量 比 0
- 振 幅 0.00%
- 历史最低 -28.7023
- 每 手 1
- 风险率 9.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多单日暴涨130%+，肾病领域再成行业焦点
转自：新康界 4月30日，诺华公司宣布以17亿美元收购美股上市医药公司Regulus(NASDAQ:RGLS)，受此消息影响，Regulus的股价...
06-23 19:50
MNC并购策略调整，中国Biotech上岸新机遇
相比2023年，2024年MNC的巨额并购交易大幅减少。 据不完全统计，2023年制药行业并购交易总金额约1500亿美元，超过50亿美元的交易就有9笔，进入T...
01-05 10:28
耐賦康被納入《2024版KDIGO IgA腎病和IgA血管炎臨床管理實踐指南（公開審查草案）》，成為指南推薦的唯一對因治療藥物
雲頂新耀（HKEX 1952.HK）是一家專注于創新藥研發、臨床開發、製造和商業化的生物製藥公司，今日宣佈耐賦康®（布地奈德腸溶膠囊，NEFECON®）作為I...
2024-09-25 09:31
Calliditas Therapeutics to be delisted from Nasdaq Stockholm
Calliditas Therapeutics AB (NASDAQ:CALT) said on Monday that Nasdaq Stockholm has decided the company will be delisted from Nasdaq Stockholm. The last day of trading in the share will be on Thursday, ...
2024-09-16 22:45
Calliditas Therapeutics Sets Delisting Process
Calliditas Therapeutics (CALT) has released an update. Calliditas Therapeutics,...
2024-09-04 04:51
Asahi Kasei Expands Global Pharma Presence with Calliditas Acquisition
Asahi Kasei (JP:3407) has released an update. Asahi Kasei Corporation successfu...
2024-09-03 09:27
Calliditas Therapeutics Sees Strong Sales Growth
Calliditas Therapeutics (CALT) has released an update. Calliditas Therapeutics ...
2024-08-14 04:38
Calliditas Therapeutics Q2 2024 GAAP EPS $(0.17) Misses $(0.13) Estimate, Sales $52.351M Beat $42.952M Estimate
Calliditas Therapeutics (NASDAQ:CALT) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.13) by 26.92 percent. This is a 49.23 percent increase over losses of $(0.33) per
2024-08-13 13:40
Novartis gets FDA approval for Fabhalta in IgAN patients
Novartis (NYSE:NVS) has received FDA accelerated approval for its drug Fabhalta to be used in the reduction of proteinuria in adults with primary immunoglobulin A nephropathy, or IgAN, at risk of rapi...
2024-08-08 04:57
Number of Shares and Votes in Calliditas Therapeutics
STOCKHOLM, July 31, 2024 /PRNewswire/ -- During July, the number of shares and ...
2024-07-31 20:23
